YHP2205

· Yuhan Corporation

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for YHP2205, covering 2024-11-12 to 2025-02-03. Get the full timeline:

Most recent: Clinical Trial Update: Bioequivalence (BE) Study Between YHP2205 and YHR2401 in Healthy Volunteers [Phase 1]